What does Metis TechBio do?

Metis TechBio uses artificial intelligence to design tiny particles, called nanomaterials, that carry active ingredients such as RNA drugs to where they need to go in living organisms. It pairs computer simulations and AI models with its own lab testing to design, improve and check these carriers faster. It operates in mainland China and the United States.

Healthcare · Biotechnology · 7666.HK

What Metis TechBio Does & How It Makes Money (7666.HK)

Updated October 2026 · reflects Metis TechBio's latest reported financials

AI-driven nanoparticle design company for delivering drugs and other active agents. It earns money by providing AI-powered nanomaterial and delivery-system design, optimization and validation to pharmaceutical companies, biotech companies and medical research institutions.

Metis TechBio's story, moat and numbers — in a 3-minute visual book.

Explore Metis TechBio on TacticScale →

How Metis TechBio makes money

It earns money by providing AI-powered nanomaterial and delivery-system design, optimization and validation to pharmaceutical companies, biotech companies and medical research institutions.

What Metis TechBio does

Metis TechBio (formerly Hangzhou Jitai Pharmaceutical Technology) was founded in 2020 and is based in Beijing. It develops AI-designed nanomaterials that deliver active agents, such as nucleic acid payloads, across carbon-based life forms. Its core offering is NanoForge, a set of linked technologies that includes a proprietary library of novel lipids, AI foundational models, the METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening. The company describes a three-layer structure. The data layer is integrated "dry-wet" lab infrastructure that links computation with experiments. The model layer is METiS's AI foundational models. The application layer is METiSAgent. On top of these it runs specialized platforms, AiTEM, AiLNP and AiRNA, which simulate and predict nanoscale interactions so it can design, optimize and validate nanomaterials and their payloads. Its customers are pharmaceutical companies, biotech companies and medical research institutions in mainland China and the US.

Products & services

NanoForge technology suite
AiLNP (lipid nanoparticle design platform)
AiRNA platform
AiTEM platform
METiS AI foundational models
METiSAgent AI agent

What is Metis TechBio worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See Metis TechBio on TacticScale →

Sector Healthcare Industry Biotechnology HQ China Ticker 7666.HK Official site

Related companies

Biocytogen Pharmaceuticals (Beijing) (2315.HK) · Bio-Techne (TECH) · InventisBio (688382.SS) · MGI Tech (688114.SS)

Understand Metis TechBio in 3 minutes →